S Wheaton
Overview
Explore the profile of S Wheaton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Tallman M, Hakimian D, Kopecky K, Wheaton S, Wollins E, Foucar K, et al.
Clin Cancer Res
. 1999 Aug;
5(7):1665-70.
PMID: 10430066
The purine nucleoside analogues 2-chlorodeoxyadenosine (2-CdA) and 2'-deoxycoformycin (2'-DCF) induce complete remission (CR) in the majority of patients with hairy cell leukemia. However, minimal residual disease (MRD) has been detected...
3.
Yokoo H, Usman I, Wheaton S, Kampmeier P
Arch Pathol Lab Med
. 1999 May;
123(5):404-10.
PMID: 10235498
Background: The histologic classification of colorectal polyps is well established. However, practicing pathologists may still occasionally encounter colorectal polyps that are difficult to classify. We studied 6 colorectal polyps that...
4.
Wheaton S, Netser J, Guinee D, Rahn M, Perkins S
Hum Pathol
. 1998 Aug;
29(8):820-5.
PMID: 9712423
Bcl-2 and bax are cellular proteins that are important in the regulation of apoptosis. Overexpression of bcl-2 protein is associated with prolonged cell survival, whereas overexpression of bax correlates with...
5.
Wheaton S, Tallman M, Hakimian D, Peterson L
Blood
. 1996 Feb;
87(4):1556-60.
PMID: 8608247
Minimal residual disease (MRD) can be detected in bone marrow core biopsies of patients with hairy cell leukemia (HCL) after treatment with 2-chlorodeoxyadenosine (2-CdA) using immunohistochemical (IHC) techniques. The purpose...